HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 1 December 2016

Latest Publications from HEDS in November

Here are the latest publications from November, including those 'In Press' by HEDS colleagues and their collaborators. 

Cooper KL, Martyn-StJames M, Kaltenthaler E, Dickinson K, Cantrell A, Ren S, et al. Complementary and alternative medicine for management of premature ejaculation: a systematic review and meta-analysis. Sex Med.

Image of PharmacoEconomics Journal
© PharmacoEconomics
Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, et al. Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics.

Kuczawski ML, Stevenson M, Goodacre S, Teare MD, Ramlakhan S, Morris F, et al. Should all anticoagulated patients with head injury receive a CT scan? Decision-analysis modelling of an observational cohort. BMJ Open.

Stevenson MD, wailoo, hernandez, gray, stevens, archer, et al. The cost-effectiveness of sequences of biological disease-modifying antirheumatic drug treatment within England for patients with rheumatoid arthritis who can tolerate methotrexate. J Rheumatol. Journal of Rheumatology.

McNamee P, Murray E, Kelly MP, Bojke L, Chilcott J, Fischer A, et al. Designing and Undertaking a Health Economics Study of Digital Health Interventions. Am J Prev Med. 2016 Nov;51(5):852–60.
Image of American Journal of  Preventive Medicine
© American Journal of
Preventive Medicine

Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, et al. Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. PharmacoEconomics - Open. 2016 Nov 4;

Lorgelly PK, Doble B, Rowen D, Brazier J, investigators C 2015. Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L. Qual Life Res [Internet]. Netherlands; 2016 Nov 9; Available from: http://www.ncbi.nlm.nih.gov/pubmed/27830513

Mulhern B, Norman R, Lorgelly P, Lancsar E, Ratcliffe J, Brazier J, et al. Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration? Pharmacoeconomics [Internet]. New Zealand; 2016 Nov 21; Available from: http://www.ncbi.nlm.nih.gov/pubmed/27873226

Image of Health and Quality of Life Outcomes
© Health and Quality of
Life Outcomes
Tong T, Thokala P, McMillan B, Ghosh R, Brazier J. Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care. Int J Geriatr Psychiatry [Internet]. England; 2016 Nov 22; Available from: http://www.ncbi.nlm.nih.gov/pubmed/27874210

Poku E, Duncan R, Keetharuth A, Essat M, Phillips P, Woods HB, et al. Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of psychometric properties. Heal Qual Life Outcomes [Internet]. England; 2016 Nov 24;14(1):161. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27881127